BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28818716)

  • 1. Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [
    Naylor JE; Hiranita T; Matazel KS; Zhang X; Paule MG; Goodwin AK
    Drug Alcohol Depend; 2017 Oct; 179():254-259. PubMed ID: 28818716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.
    Mukherjee J; Christian BT; Narayanan TK; Shi B; Collins D
    Brain Res; 2005 Jan; 1032(1-2):77-84. PubMed ID: 15680944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
    Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
    Ota M; Ogawa S; Kato K; Masuda C; Kunugi H
    Neurosci Res; 2015 Dec; 101():1-5. PubMed ID: 26232153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis.
    Vandehey NT; Garell PC; Hampel JA; Murali D; Smith EM; Davidson R; Converse AK; Nickles RJ; Christian BT
    J Neurosci Methods; 2009 Jan; 176(2):129-35. PubMed ID: 18824196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
    Riccardi P; Baldwin R; Salomon R; Anderson S; Ansari MS; Li R; Dawant B; Bauernfeind A; Schmidt D; Kessler R
    Biol Psychiatry; 2008 Jan; 63(2):241-4. PubMed ID: 17586476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
    Landvogt C; Buchholz HG; Bernedo V; Schreckenberger M; Werhahn KJ
    Epilepsia; 2010 Sep; 51(9):1699-706. PubMed ID: 20384765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.
    Christian BT; Lehrer DS; Shi B; Narayanan TK; Strohmeyer PS; Buchsbaum MS; Mantil JC
    Neuroimage; 2006 May; 31(1):139-52. PubMed ID: 16469510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.
    Slifstein M; Kegeles LS; Xu X; Thompson JL; Urban N; Castrillon J; Hackett E; Bae SA; Laruelle M; Abi-Dargham A
    Synapse; 2010 May; 64(5):350-62. PubMed ID: 20029833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D
    Pfeifer P; Tüscher O; Buchholz HG; Gründer G; Vernaleken I; Paulzen M; Zimmermann US; Maus S; Lieb K; Eggermann T; Fehr C; Schreckenberger M
    Addict Biol; 2017 Sep; 22(5):1449-1458. PubMed ID: 27396374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
    Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
    Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
    Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations.
    Vernaleken I; Peters L; Raptis M; Lin R; Buchholz HG; Zhou Y; Winz O; Rösch F; Bartenstein P; Wong DF; Schäfer WM; Gründer G
    J Cereb Blood Flow Metab; 2011 Sep; 31(9):1958-66. PubMed ID: 21587267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy.
    Yakushev IY; Dupont E; Buchholz HG; Tillmanns J; Debus F; Cumming P; Heimann A; Fellgiebel A; Luhmann HJ; Landvogt C; Werhahn KJ; Schreckenberger M; Potschka H; Bartenstein P
    Epilepsia; 2010 Mar; 51(3):415-22. PubMed ID: 19694792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized in vivo detection of dopamine release using 18F-fallypride PET.
    Ceccarini J; Vrieze E; Koole M; Muylle T; Bormans G; Claes S; Van Laere K
    J Nucl Med; 2012 Oct; 53(10):1565-72. PubMed ID: 22933820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
    Kegeles LS; Slifstein M; Xu X; Urban N; Thompson JL; Moadel T; Harkavy-Friedman JM; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2010 Oct; 68(7):634-41. PubMed ID: 20673873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.